{"id":"W2999203985","doi":"10.1016/s2213-2600(19)30267-x","title":"Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: a multicentre, open-label, phase 1 study","year":2020,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Medical Research Council; Novartis Institutes for BioMedical Research; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Oncology; Open label; Internal medicine; Lung; Phases of clinical research; Small Cell Lung Carcinoma; Carcinoma; Mutant; Small-cell carcinoma; Clinical trial; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004614741,0.0002512807,0.0008934004,0.00007368978,0.00009676923,0.00001150437,0.0002644383,0.00004571352,0.00006390632],"category_scores_gemma":[0.0001603011,0.0001360603,0.00001877207,0.0004764729,0.000178474,0.00007312903,0.0001221056,0.000291335,0.000004305946],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008956592,"about_ca_system_score_gemma":0.0002589707,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004030464,"about_ca_topic_score_gemma":0.0002190013,"domain_scores_codex":[0.9982296,0.0001460599,0.000553721,0.000429814,0.0003165065,0.0003242606],"domain_scores_gemma":[0.9986779,0.0002174986,0.000234081,0.000501066,0.0001196267,0.0002498449],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.06833729,0.01001156,0.7668893,0.00180717,0.0008638809,0.001715348,0.1201809,0.00005219763,0.01441734,0.00009673339,0.003323031,0.01230533],"study_design_scores_gemma":[0.5492612,0.0240442,0.3955855,0.002057388,0.002131712,0.0000279454,0.01680981,0.002135734,0.002194074,0.000003325369,0.005354325,0.0003948522],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861437,0.002201222,0.00003599113,0.005457447,0.00005211156,0.003795455,0.00003035867,0.000029505,0.002254173],"genre_scores_gemma":[0.9963323,0.00008989293,0.0001250943,0.00289598,0.0003665757,0.00008980028,0.00001892951,0.00003191665,0.00004948228],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4809238,"threshold_uncertainty_score":0.5548378,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05330810440844667,"score_gpt":0.3645879452239147,"score_spread":0.311279840815468,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}